Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Journal of Endourology|May 25, 2017
Utilization and Outcomes of Nephroureterectomy for Upper Tract Urothelial Carcinoma by Surgical ApproachJoseph F Rodriguez, Vignesh T Packiam, William R Boysen, et al.
Urologic Oncology|June 1, 2025
Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma (AVETAX trial)Rohan Garje, Aditya Ravindra, Bilal Rahim, et al.
Translational Andrology and Urology|September 8, 2023
Immediate gemcitabine bladder instillation following bladder closure during robotic-assisted radical nephroureterectomy: a multi-institutional report of feasibility and initial outcomesMohammed A Said, Hayden Warner, Thomas E Stout, et al.
Urologic Oncology|August 13, 2025
Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinomaKyle Moore, Helen Gao, Benjamin Lichtbroun, et al.
Cancers|January 28, 2026
Impact of Computational Histology AI Biomarkers on Clinical Management Decisions in Non-Muscle Invasive Bladder Cancer: A Multi-Center Real-World StudyVignesh T Packiam, Saum Ghodoussipour, Badrinath R Konety, et al.
Urology|April 22, 2024
The Association Between Duration of Antibiotics and Infectious Complications Following Radical Cystectomy: Analysis of the 2019-2021 NSQIP DatabaseRachel Passarelli, John Pfail, Alain Kaldany, et al.
BJUI Compass|May 18, 2026
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancerJacob Hanna, Melinda Z Fu, Berk Inan, et al.
The Journal of Urology|July 27, 2022
Reply by AuthorsIan M McElree, Ryan L Steinberg, Alex C Martin, et al.
Bladder (San Francisco, Calif.)|August 1, 2025
Tolerability and efficacy of induction Bacillus Calmette-Guérin for non-muscle invasive bladder cancerMann Patel, Aravind Rajagopalan, Ellen M Cahill, et al.
Infection Control and Hospital Epidemiology|November 7, 2024
A pilot intervention trial to reduce the use of post-procedural antimicrobials after common endourologic surgeriesDaniel J Livorsi, Vignesh T Packiam, Qianyi Shi, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Journal of Endourology|May 25, 2017
Utilization and Outcomes of Nephroureterectomy for Upper Tract Urothelial Carcinoma by Surgical ApproachJoseph F Rodriguez, Vignesh T Packiam, William R Boysen, et al.
Urologic Oncology|June 1, 2025
Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma (AVETAX trial)Rohan Garje, Aditya Ravindra, Bilal Rahim, et al.
Translational Andrology and Urology|September 8, 2023
Immediate gemcitabine bladder instillation following bladder closure during robotic-assisted radical nephroureterectomy: a multi-institutional report of feasibility and initial outcomesMohammed A Said, Hayden Warner, Thomas E Stout, et al.
Urologic Oncology|August 13, 2025
Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinomaKyle Moore, Helen Gao, Benjamin Lichtbroun, et al.
Cancers|January 28, 2026
Impact of Computational Histology AI Biomarkers on Clinical Management Decisions in Non-Muscle Invasive Bladder Cancer: A Multi-Center Real-World StudyVignesh T Packiam, Saum Ghodoussipour, Badrinath R Konety, et al.
Urology|April 22, 2024
The Association Between Duration of Antibiotics and Infectious Complications Following Radical Cystectomy: Analysis of the 2019-2021 NSQIP DatabaseRachel Passarelli, John Pfail, Alain Kaldany, et al.
BJUI Compass|May 18, 2026
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancerJacob Hanna, Melinda Z Fu, Berk Inan, et al.
The Journal of Urology|July 27, 2022
Reply by AuthorsIan M McElree, Ryan L Steinberg, Alex C Martin, et al.
Bladder (San Francisco, Calif.)|August 1, 2025
Tolerability and efficacy of induction Bacillus Calmette-Guérin for non-muscle invasive bladder cancerMann Patel, Aravind Rajagopalan, Ellen M Cahill, et al.
Infection Control and Hospital Epidemiology|November 7, 2024
A pilot intervention trial to reduce the use of post-procedural antimicrobials after common endourologic surgeriesDaniel J Livorsi, Vignesh T Packiam, Qianyi Shi, et al.
Pageof 14